CLINICAL_TRIALS ClinicalTrials.gov record update

Early Access Program (EAP) for Danicopan as Add-on Treatment to SOLIRIS® or ULTOMIRIS® in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Clinically Significant Extravascular Hemolysis (csEVH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05982938
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:17.559075+00:00
Published At: 2026-03-06T00:00:00+00:00
Record Updated At: 2026-03-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Paroxysmal Nocturnal Hemoglobinuria", "PNH", "Extravascular Hemolysis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-06"
protocolSection.identificationModule.nctId: "NCT05982938"
protocolSection.identificationModule.officialTitle: "Early Access Program (EAP) for Danicopan as Add-on Treatment to SOLIRIS\u00ae or ULTOMIRIS\u00ae in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Clinically Significant Extravascular Hemolysis (csEVH)"
protocolSection.statusModule.overallStatus: "AVAILABLE"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.